NCT04172675 · Interventional trial
A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
Overall registry status Completed
Phase 2
Conditions Urinary Bladder Neoplasms
Delaware Valley sites
- MidLantic Urology · Bala-Cynwyd, PA · Montgomery County
First posted
Registry updated
Added to the directory